Publications show all

Retrophin has published 7 articles.

Patents show all

11Applications11Issued

Clinical Trials show all

4Phase 32N/A1Phase 2

SEC Filings show all

8-K8510-Q2810-K9D1S-11

Private Funding Events

DateOfferedSoldType
2013-10-07$24,916,307$24,916,307Equity, Option to Acquire

Contact Information

    Key Executives

    • Martin Shkreli
      Executive Officer, Director
    • Marc Panoff
      Executive Officer
    • Horacio Plotkin
      Executive Officer
    • Stephen Aselage
      Director
    • Steve Richardson
      Director